ES8700672A1 - Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos. - Google Patents

Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.

Info

Publication number
ES8700672A1
ES8700672A1 ES537293A ES537293A ES8700672A1 ES 8700672 A1 ES8700672 A1 ES 8700672A1 ES 537293 A ES537293 A ES 537293A ES 537293 A ES537293 A ES 537293A ES 8700672 A1 ES8700672 A1 ES 8700672A1
Authority
ES
Spain
Prior art keywords
phenobarbital
carbamazepine
enzyme inhibitors
chem
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES537293A
Other languages
English (en)
Other versions
ES537293A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/548,743 external-priority patent/US4543412A/en
Priority claimed from US06/548,742 external-priority patent/US4559173A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES537293A0 publication Critical patent/ES537293A0/es
Publication of ES8700672A1 publication Critical patent/ES8700672A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

METODO DE PREPARACION DE DERIVADOS DE AMINOALQUILENTIOALQUILENTIOFOSFONATOS. CONJUGADOS DE FENOBARBITAL Y CARBAMAZEPINA DE FORMULA (I) QUE PUEDEN SER UTILIZADOS COMO INHIBIDORES DE ENZIMAS. PARA LA OBTENCION SE HACE REACCIONAR UN ANALOGO DE 5-HIDROXI-FENOBARBITAL CON FOSGENO PARA DAR EL CORRESPONDIENTE DERIVADO DE CLORURO DE ACETILO. UN FOSFONATO PROTEGIDO CON N-BUTOXICARBONILO SE TRANSFORMA EN LA CORRESPONDIENTE SAL TRIFLUOROACETICA. POR REACCION DEL CLORURO DE ACETILO Y LA SAL SE PREPARA LA AMIDA DEL FENOBARBITAL. EL METODO DESCRITO CONSTITUYE UNA TECNICA DE INMUNOENSAYO CONVENIENTE PARA MEDIR LA CANTIDAD PRESENTE DE DIVERSAS DROGAS, Y HORMONAS EN FLUIDOS BIOLOGICOS.
ES537293A 1983-11-04 1984-10-31 Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos. Expired ES8700672A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/548,743 US4543412A (en) 1983-11-04 1983-11-04 Phenobarbital enzyme inhibitors
US06/548,742 US4559173A (en) 1983-11-04 1983-11-04 N-substituted dibenz[b,f]azepine salts

Publications (2)

Publication Number Publication Date
ES537293A0 ES537293A0 (es) 1986-10-16
ES8700672A1 true ES8700672A1 (es) 1986-10-16

Family

ID=27068936

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537293A Expired ES8700672A1 (es) 1983-11-04 1984-10-31 Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.

Country Status (10)

Country Link
EP (1) EP0141393B1 (es)
KR (1) KR900001620B1 (es)
AU (1) AU566518B2 (es)
CA (1) CA1224783A (es)
DE (1) DE3473456D1 (es)
DK (1) DK522884A (es)
ES (1) ES8700672A1 (es)
GR (1) GR80827B (es)
IE (1) IE58318B1 (es)
IL (1) IL73293A (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414085A (en) * 1992-04-06 1995-05-09 Biosite Diagnostics, Inc. Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
US9303038B2 (en) 2011-09-06 2016-04-05 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy and neurological diseases
WO2013167990A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of depression
SG11201407300VA (en) * 2012-05-07 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of neurological disorders
WO2013168021A1 (en) 2012-05-07 2013-11-14 Mahesh Kandula Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
US9309233B2 (en) 2012-05-08 2016-04-12 Cellix Bio Private Limited Compositions and methods for the treatment of blood clotting disorders
WO2013167993A1 (en) 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological degenerative disorders
US9522884B2 (en) 2012-05-08 2016-12-20 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic disorders
US9266823B2 (en) 2012-05-08 2016-02-23 Cellix Bio Private Limited Compositions and methods for the treatment of parkinson's disease
US9403826B2 (en) 2012-05-08 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory disorders
WO2013168014A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of familial amyloid polyneuropathy
WO2013167997A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
US9346742B2 (en) 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
US9403857B2 (en) 2012-05-10 2016-08-02 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9242939B2 (en) 2012-05-10 2016-01-26 Cellix Bio Private Limited Compositions and methods for the treatment of respiratory disorders
US9339484B2 (en) 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9273061B2 (en) 2012-05-10 2016-03-01 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
US9499526B2 (en) 2012-05-10 2016-11-22 Cellix Bio Private Limited Compositions and methods for the treatment of neurologic diseases
WO2013167999A2 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurologic diseases
US9573927B2 (en) 2012-05-10 2017-02-21 Cellix Bio Private Limited Compositions and methods for the treatment of severe pain
US9233161B2 (en) 2012-05-10 2016-01-12 Cellix Bio Private Limited Compositions and methods for the treatment of neurological conditions
WO2013168001A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
WO2013168015A1 (en) 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of asthma and allergy
JP2015518854A (ja) 2012-05-23 2015-07-06 セリックスビオ プライヴェート リミテッド 多発性硬化症の治療のための組成物および方法
WO2013175376A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of local pain
US9434729B2 (en) 2012-05-23 2016-09-06 Cellix Bio Private Limited Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
NZ701832A (en) 2012-05-23 2016-08-26 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
WO2013175347A2 (en) 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of respiratory disorders
SG11201407326XA (en) 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of mucositis
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
US9187427B2 (en) 2012-08-03 2015-11-17 Cellix Bio Private Limited N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
WO2014037833A2 (en) 2012-09-06 2014-03-13 Mahesh Kandula Compositions and methods for the treatment inflammation and lipid disorders
AU2013311349A1 (en) 2012-09-08 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of inflammation and lipid disorders
US9333187B1 (en) 2013-05-15 2016-05-10 Cellix Bio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
AU2014276346A1 (en) 2013-06-04 2015-12-24 Cellixbio Private Limited Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en) 2014-12-31 2015-08-04 Mahesh Kandula Compositions and methods for the treatment of mucositis
SG11201706952VA (en) 2014-09-26 2017-10-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy and neurological disorders
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis
AU2014414316B2 (en) 2014-10-27 2020-04-09 Cellix Bio Private Limited Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
US9321716B1 (en) 2014-11-05 2016-04-26 Cellix Bio Private Limited Compositions and methods for the treatment of metabolic syndrome
US9173877B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Compositions and methods for the treatment of local pain
US9175008B1 (en) 2014-11-05 2015-11-03 Cellix Bio Private Limited Prodrugs of anti-platelet agents
US9284287B1 (en) 2014-11-05 2016-03-15 Cellix Bio Private Limited Compositions and methods for the suppression of carbonic anhydrase activity
US9150557B1 (en) 2014-11-05 2015-10-06 Cellix Bio Private Limited Compositions and methods for the treatment of hyperglycemia
US10208014B2 (en) 2014-11-05 2019-02-19 Cellix Bio Private Limited Compositions and methods for the treatment of neurological disorders
US9290486B1 (en) 2014-11-05 2016-03-22 Cellix Bio Private Limited Compositions and methods for the treatment of epilepsy
WO2016088132A1 (en) 2014-12-01 2016-06-09 Cellix Bio Private Limited Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en) 2014-12-17 2015-12-08 Cellix Bio Private Limited Compositions and methods for the treatment of neurological diseases
JP6679616B2 (ja) 2015-01-06 2020-04-22 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 炎症及び疼痛の治療のための組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273866A (en) * 1979-02-05 1981-06-16 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Also Published As

Publication number Publication date
EP0141393A2 (en) 1985-05-15
ES537293A0 (es) 1986-10-16
DK522884A (da) 1985-05-05
AU3471284A (en) 1985-05-09
DK522884D0 (da) 1984-11-02
IL73293A (en) 1988-02-29
IE58318B1 (en) 1993-09-08
GR80827B (en) 1985-03-05
IE842828L (en) 1985-05-04
CA1224783A (en) 1987-07-28
KR900001620B1 (ko) 1990-03-17
DE3473456D1 (en) 1988-09-22
KR850004111A (ko) 1985-07-01
IL73293A0 (en) 1985-01-31
EP0141393A3 (en) 1985-07-03
EP0141393B1 (en) 1988-08-17
AU566518B2 (en) 1987-10-22

Similar Documents

Publication Publication Date Title
AU3530795A (en) Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
MY101843A (en) Block polyesters and like compounds useful as soil release agents in detergent compositions.
ES8502105A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
KR850004111A (ko) 페노바비탈 및 카밤아제핀 공액체의 제조방법
NO855241L (no) Fremgangsmaate til fremstilling av karbapenemforbindelser.
AU578395B2 (en) Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkyl-pyrazoline- 3-one compounds
EP0809622A4 (en) ANTI-INFLAMMATORY DERIVATIVES OF BENZOIC ACID
ATE50773T1 (de) Alkylresorcinolphosphite.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE42091T1 (de) N-(6-methoxy-5(perfluoralkyl)-1-naphthoyl)-nmethylglycine und ihre thionaphthoylanaloga.
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
FR2540870B1 (es)
AP8800109A0 (en) "Heterocyclic insecticides".
ES8801545A1 (es) Un procedimiento para la preparacion de compuestos aminoheterociclicos
UA19160A (uk) Спосіб одержаhhя алкілаhіліhофумарату
ES8704918A1 (es) Un procedimiento para la preparacion de nuevos derivados de esteres fosforicos.
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES2066756T3 (es) Nuevos derivados de tironina.
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
FR2422683A1 (fr) Nouvelles 6'-n-alkyl- et 6',6'-di-n-alkylfortimicines a et b, utiles notamment comme antibiotiques, et leur procede de preparation
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES2000677A6 (es) Procedimiento para la obtencion de superficies permanentemente antiestaticas
ES8303400A1 (es) "procedimiento para preparar derivados de bencilazol."
IT1214534B (it) 4-cloro-arilossi-acetil-e 4-cloro-arilossi-propionil-malonati aventi proprieta' erbicide.
MY105843A (en) Glycerol derivatives, a preparation process of the same and therapeutical compositions containing them.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401